clinical trial · NCT07527078
Evaluate the Efficacy and Safety of GZR33 Injection in Patients With Type 2 Diabetes
Type 2 Diabetes (T2DM)GZR33 InjectionInsulin Degludec Injection (Tresiba®)
brief summary
Evaluate the efficacy of GZR33 Injection and Insulin Degludec Injection (Tresiba®) in Patients with Type 2 Diabetes Mellitus Inadequately Controlled with Oral Antidiabetic Drugs.
started
Apr 7, 2026
primary completion
Apr 10, 2027
completion
Apr 17, 2027
last updated
Apr 14, 2026
detailed description
This study will be conducted to evaluate the efficacy of once-daily GZR33 Injection and once-daily Insulin Degludec Injection (Tresiba®) in Patients with Type 2 Diabetes Mellitus Inadequately Controlled with Oral Antidiabetic Drugs.
official title
A Randomized, Open-label, Parallel-controlled, Multicenter Phase III Clinical Study Comparing the Efficacy and Safety of GZR33 Injection and Insulin Degludec Injection in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Oral Antidiabetic Drugs
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol